IL10 and type 1 diabetes mellitus: So far in type 1 diabetes, the studies employing CD40L and TLR stimulants - either LPS [TLR4] or CpG [TLR9] in culture before assessment, or with PMA/ionomycin alone - have shown a decrease in numerical frequency of IL-10-producing B cells from peripheral blood samples (28–30).